Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Vascular Diseases

cetylpyridinium chloride anhydrous has been researched along with Vascular Diseases in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-199012 (44.44)18.7374
1990's9 (33.33)18.2507
2000's4 (14.81)29.6817
2010's2 (7.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fearnley, GW; Harrison, MA; Ponnambalam, S; Smith, GA; Tomlinson, DC; Wheatcroft, SB1
Schini-Kerth, V; Stoclet, JC1
De Silva, V; Fortney, JA; Grubb, GS; Salgado, M; Thapa, S1
Cho, AJ; Kong, SK; Meng, K1
Belaisch, J; Hommais-loufrani, B1
Price, TG1
Wen, W1
Maclennan, AH1
Chervenak, JL; Kardon, NB1
Moodley, J1
Ory, HW1
JORKE, D1
FREUND, J; WARD, C1
INK, J1
BATISTA, G; BROWN, LC; FAIRLEY, AI; JOHNSON, JB; LAWLAH, JW1
Hopkin, K2
Elwood, P; Longley, M; Morgan, G1
Kava, R; Meister, KA; Whelan, EM1
Fletcher, CM; Horn, D1

Reviews

6 review(s) available for cetylpyridinium chloride anhydrous and Vascular Diseases

ArticleYear
Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease.
    Journal of inherited metabolic disease, 2015, Volume: 38, Issue:4

    Topics: Animals; Disease; Health; Humans; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Diseases; Vascular Endothelial Growth Factor A

2015
[Dietary flavonoids and human health].
    Annales pharmaceutiques francaises, 2011, Volume: 69, Issue:2

    Topics: Chronic Disease; Diet; Endothelium, Vascular; Epidemiologic Studies; Flavonoids; Health; Humans; Oxidation-Reduction; Phosphorylation; Plants; Vascular Diseases

2011
Appendix: vitamin E and health: background and objectives.
    Annals of the New York Academy of Sciences, 2004, Volume: 1031

    Topics: Antioxidants; Cell Physiological Phenomena; Clinical Trials as Topic; Diet; Health; Humans; Oxidative Stress; Preventive Medicine; Signal Transduction; Vascular Diseases; Vitamin E

2004
My health: whose responsibility? Low-dose aspirin and older people.
    Expert review of cardiovascular therapy, 2006, Volume: 4, Issue:5

    Topics: Aged; Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Health; History, 19th Century; History, 20th Century; Humans; Neoplasms; Self Care; Vascular Diseases

2006
The health effects of moderate alcohol intake in humans: an epidemiologic review.
    Critical reviews in clinical laboratory sciences, 2000, Volume: 37, Issue:3

    Topics: Alcohol Drinking; Diabetes Mellitus, Type 2; Epidemiologic Methods; Female; Gallbladder Diseases; Health; Humans; Mortality; Pregnancy; Risk Factors; Stroke; Vascular Diseases

2000
Smoking and health.
    WHO chronicle, 1970, Volume: 24, Issue:8

    Topics: Adult; Age Factors; Body Weight; Bronchitis; Coronary Disease; Female; Health; Health Education; Humans; Lung Neoplasms; Male; Middle Aged; Mortality; Neoplasms; Peptic Ulcer; Pregnancy; Prospective Studies; Public Health Administration; Pulmonary Emphysema; Retrospective Studies; Sex Factors; Smoking; Smoking Prevention; Tuberculosis, Pulmonary; Vascular Diseases

1970

Other Studies

21 other study(ies) available for cetylpyridinium chloride anhydrous and Vascular Diseases

ArticleYear
Women's perceptions of the pill's potential health risks in Sri Lanka.
    Asia-Pacific population journal, 1987, Volume: 2, Issue:3

    Topics: Asia; Attitude; Behavior; Body Weight; Cardiovascular System; Cerebrovascular Circulation; Communication; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Demography; Developing Countries; Disease; Economics; Education; Educational Status; Employment; Family Planning Services; Fertility; Health; Health Knowledge, Attitudes, Practice; Health Planning; Health Services Needs and Demand; Heart Diseases; Infections; Infertility; Information Services; Knowledge; Organization and Administration; Patient Acceptance of Health Care; Perception; Population; Population Dynamics; Psychology; Research; Sexual Behavior; Sexually Transmitted Diseases; Social Change; Social Class; Social Planning; Socioeconomic Factors; Sri Lanka; Statistics as Topic; Urogenital System; Vascular Diseases

1987
[[A case-control study on risk factors for the major cardiovascular deaths in Korean men: hypertensive disease and cerebrovascular disease]].
    In'gu pogon nonjip = Journal of population and health studies, 1987, Volume: 7, Issue:1

    Topics: Alcohol Drinking; Asia; Asia, Eastern; Behavior; Biology; Body Weight; Cardiovascular System; Cause of Death; Cerebrovascular Circulation; Christianity; Demography; Developing Countries; Diabetes Mellitus; Disease; Economics; Educational Status; Family Characteristics; Family Relations; Health; Heart Diseases; Hypertension; Korea; Mortality; Nutritional Physiological Phenomena; Obesity; Parents; Physiology; Population; Population Characteristics; Population Dynamics; Religion; Research; Social Class; Socioeconomic Factors; Vascular Diseases

1987
[Oral contraception: evolution of concepts over the last thirty years].
    Contraception, fertilite, sexualite, 1987, Volume: 15, Issue:11 Suppl

    Topics: Arterial Occlusive Diseases; Attitude; Behavior; Cardiovascular System; Cerebrovascular Circulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delivery of Health Care; Demography; Developed Countries; Disease; Economics; Europe; Family Planning Services; France; Health; Health Personnel; Physicians; Population; Population Dynamics; Progesterone Congeners; Psychology; Research; Technology; Time; Time Factors; Vascular Diseases; Veins

1987
Preliminary report on maternal deaths in the Southern Highlands of Tanzania in 1983.
    Journal of obstetrics & gynaecology of Eastern and Central Africa, 1984, Volume: 3, Issue:3

    Topics: Abortion, Septic; Africa; Africa South of the Sahara; Africa, Eastern; Cause of Death; Cervix Uteri; Cesarean Section; Delivery of Health Care; Delivery, Obstetric; Demography; Developing Countries; Disease; Embolism; Endometritis; General Surgery; Health; Health Facilities; Health Services; Health Surveys; Hospitals; Infections; Maternal Mortality; Medical Errors; Medicine; Mortality; Obstetric Surgical Procedures; Plants, Medicinal; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy, Ectopic; Pulmonary Embolism; Reproduction; Research; Rural Health Services; Tanzania; Therapeutics; Vascular Diseases

1984
Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contraception Report, 1994, Volume: 5, Issue:1

    Topics: Age Factors; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developed Countries; Disease; Drug Interactions; Economics; Embolism; Family Planning Services; Health; Health Planning Guidelines; Marketing of Health Services; North America; Pharmaceutical Preparations; Population; Population Characteristics; Product Packaging; Public Health; Safety; Therapeutics; Thromboembolism; United States; Vascular Diseases

1994
Hypertension a priority?
    Africa health, 1998, Volume: 20, Issue:5

    Topics: Africa; Developing Countries; Diet; Disease; Economics; Health; Health Services Needs and Demand; Hypertension; Nutritional Physiological Phenomena; Pharmaceutical Preparations; Therapeutics; Vascular Diseases

1998
China: a new medicine born of tradition.
    The Unesco courier, 1979, Volume: 7

    Topics: Asia; Asia, Eastern; China; Community Health Workers; Contraception; Delivery of Health Care; Developing Countries; Disease; Endometrial Neoplasms; Family Planning Services; Health; Health Personnel; Health Services; Heart Diseases; Hypertension; Medicine; Neoplasms; Plants, Medicinal; Pregnancy; Pregnancy Complications; Pregnancy, Ectopic; Vascular Diseases

1979
Oral contraceptives.
    Current therapeutics, 1987, Volume: 28, Issue:12

    Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases

1987
Advancing maternal age: the actual risks.
    Female patient, 1991, Volume: 16, Issue:11

    Topics: Age Factors; Americas; Amniocentesis; Cesarean Section; Clinical Laboratory Techniques; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Delivery of Health Care; Demography; Developed Countries; Diabetes Mellitus; Diagnosis; Disease; Fetal Death; General Surgery; Genetic Techniques; Health; Health Services; Hypertension; Infant Mortality; Mass Screening; Maternal Age; Maternal Health Services; Maternal Mortality; Maternal-Child Health Centers; Morbidity; Mortality; North America; Obstetric Surgical Procedures; Parents; Population; Population Characteristics; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Care; Primary Health Care; Reproduction; Therapeutics; Ultrasonics; United States; Vascular Diseases

1991
Pill research results in new guidance from CSM.
    Family planning today, 1995

    Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases

1995
Coping with hypertension in pregnancy.
    Africa health, 1993, Volume: 15, Issue:3

    Topics: Africa; Africa South of the Sahara; Africa, Southern; Delivery of Health Care; Developing Countries; Diet; Disease; Health; Health Services; Hypertension; Maternal Health Services; Maternal-Child Health Centers; Nutritional Physiological Phenomena; Pharmaceutical Preparations; Pregnancy Complications; Prenatal Care; Primary Health Care; South Africa; Therapeutics; Vascular Diseases

1993
Public Prosecutor v. Dr. Nadason Kanagalingam, 9 June 1984.
    Annual review of population law, 1987, Volume: 14

    Topics: Abortion, Induced; Abortion, Therapeutic; Asia; Asia, Southeastern; Crime; Delivery of Health Care; Developing Countries; Disease; Embolism; Family Planning Services; Health; Health Personnel; Jurisprudence; Legislation as Topic; Malaysia; Physicians; Pulmonary Embolism; Social Problems; Vascular Diseases

1987
Epidemiology of venous thromboembolic disease and OC use.
    Dialogues in contraception, 1996,Fall, Volume: 5, Issue:1

    Topics: Bias; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Disease; Embolism; Epidemiology; Family Planning Services; Health; Public Health; Research; Research Design; Risk Factors; Thromboembolism; Vascular Diseases

1996
2 methods for prescribing third-generation OCs.
    Contraceptive technology update, 1997, Volume: 18, Issue:12

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Europe; Family Planning Services; Health; Health Personnel; Health Planning; Health Planning Guidelines; Organization and Administration; Physicians; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases

1997
Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contraceptive technology update, 1997, Volume: 18, Issue:12

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; England; Europe; Family Planning Services; Health; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases

1997
[Blood sugar increase after 1-noradrenalin in health and liver disease].
    Arztliche Wochenschrift, 1956, Dec-14, Volume: 11, Issue:50

    Topics: Blood Glucose; Health; Liver Diseases; Norepinephrine; Vascular Diseases

1956
The acute effect of cigarette smoking on the digital circulation in health and disease.
    Annals of the New York Academy of Sciences, 1960, Sep-27, Volume: 90

    Topics: Blood Circulation; Health; Nicotiana; Peripheral Vascular Diseases; Physiological Phenomena; Smoking; Vascular Diseases

1960
[Man facing his environment: a common mechanism of health, disease, old age and death. The connectivomicrovascular syndrome in clinical and experimental pathology, and in old age].
    La Semana medica, 1960, Sep-22, Volume: 117

    Topics: Blood Vessels; Death; Disease; Health; Humans; Male; Syndrome; Vascular Diseases

1960
Clinical arteriography in health and disease.
    The Medical annals of the District of Columbia, 1961, Volume: 30

    Topics: Angiography; Health; Humans; Peripheral Vascular Diseases; Vascular Diseases

1961
Overview: New roles for a familiar nutrient.
    Annals of the New York Academy of Sciences, 2004, Volume: 1031

    Topics: Animals; Antioxidants; Biological Availability; Cell Physiological Phenomena; Health; Humans; Oxidative Stress; Preventive Medicine; Vascular Diseases; Vitamin E

2004
Growth hormone therapy in elderly people.
    Lancet (London, England), 1991, May-11, Volume: 337, Issue:8750

    Topics: Adult; Aged; Aging; Body Composition; Growth Hormone; Health; Humans; Insulin-Like Growth Factor I; Risk Assessment; Therapeutic Human Experimentation; Vascular Diseases

1991